Biopharmaceutical Alliance

In June 2024, South Korea, India, the United States, and Japan launched the Biopharmaceutical Alliance to tackle global drug supply shortages, particularly those experienced during the COVID-19 pandemic.

  • This strategic initiative aims to strengthen international collaboration in the biopharmaceutical sector.
  • The inaugural meeting of the alliance was held in San Diego, USA, during the Bio International Convention 2024, the world’s largest pharmaceutical exhibition.
  • The alliance focuses on enhancing vaccination diplomacy and ensuring a stable and secure global supply of biopharmaceutical products.
  • It seeks to align bio policies, regulatory frameworks, and research and development (R&D) efforts across participating nations.

Do You Want to Read More?
Subscribe Now

To get access to detailed content

Already a Member? Login here


Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.

Related Content